Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
20517 | 456 | 39.3 | 88% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
422 | 3 | C REACTIVE PROTEIN//STAT3//HAPTOGLOBIN | 28303 |
1051 | 2 | STAT3//GP130//ONCOSTATIN M | 10071 |
20517 | 1 | INTERLEUKIN 11//IL 11//RECOMBINANT HUMAN INTERLEUKIN 11 | 456 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | INTERLEUKIN 11 | authKW | 2734448 | 21% | 43% | 95 |
2 | IL 11 | authKW | 1286157 | 11% | 39% | 49 |
3 | RECOMBINANT HUMAN INTERLEUKIN 11 | authKW | 665680 | 3% | 76% | 13 |
4 | INTERLEUKIN 11 RECEPTOR | authKW | 623263 | 2% | 85% | 11 |
5 | RHIL 11 | authKW | 209254 | 1% | 63% | 5 |
6 | GRP RECH CYTOKINES RECEPTEURS | address | 193001 | 2% | 41% | 7 |
7 | IL 11 RECEPTOR | authKW | 150664 | 1% | 75% | 3 |
8 | ADIPOGENESIS INHIBITORY FACTOR | authKW | 133925 | 0% | 100% | 2 |
9 | ENDOCRINOL BONE METAB BREAST CANC | address | 133925 | 0% | 100% | 2 |
10 | GP130 TARGETING | authKW | 133925 | 0% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Hematology | 1997 | 21% | 0% | 94 |
2 | Oncology | 483 | 18% | 0% | 84 |
3 | Immunology | 476 | 17% | 0% | 77 |
4 | Cell Biology | 307 | 15% | 0% | 68 |
5 | Cell & Tissue Engineering | 189 | 2% | 0% | 9 |
6 | Biochemistry & Molecular Biology | 157 | 19% | 0% | 88 |
7 | Medicine, Research & Experimental | 142 | 8% | 0% | 35 |
8 | Gastroenterology & Hepatology | 100 | 5% | 0% | 24 |
9 | Reproductive Biology | 62 | 3% | 0% | 12 |
10 | Biophysics | 48 | 5% | 0% | 22 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | GRP RECH CYTOKINES RECEPTEURS | 193001 | 2% | 41% | 7 |
2 | ENDOCRINOL BONE METAB BREAST CANC | 133925 | 0% | 100% | 2 |
3 | LINK SCYTOKINE CYTOKINE RECEPTOR | 89282 | 0% | 67% | 2 |
4 | ABM PRO TOSS | 66963 | 0% | 100% | 1 |
5 | BIRMINGHAMS VET AFFAIRS MED | 66963 | 0% | 100% | 1 |
6 | CANC CAMPAIGN GROWTH TOR GRP | 66963 | 0% | 100% | 1 |
7 | CARDIAC N SHORE LONG ISL JEWISH MED | 66963 | 0% | 100% | 1 |
8 | DEOT DIGEST DIS | 66963 | 0% | 100% | 1 |
9 | EQUIPE ONCOGENESE DEV | 66963 | 0% | 100% | 1 |
10 | GRAS BIOMED SCI | 66963 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EXPERIMENTAL HEMATOLOGY | 2622 | 3% | 0% | 15 |
2 | JOURNAL OF INTERFERON AND CYTOKINE RESEARCH | 2399 | 2% | 0% | 9 |
3 | BLOOD | 1607 | 6% | 0% | 29 |
4 | STEM CELLS | 985 | 2% | 0% | 8 |
5 | CYTOKINE | 958 | 2% | 0% | 8 |
6 | INTERNATIONAL REVIEW OF EXPERIMENTAL PATHOLOGY | 630 | 0% | 1% | 1 |
7 | JOURNAL OF ENDOTOXIN RESEARCH | 482 | 0% | 0% | 2 |
8 | ARTHRITIS RESEARCH | 366 | 0% | 1% | 1 |
9 | CYTOKINE & GROWTH FACTOR REVIEWS | 331 | 0% | 0% | 2 |
10 | CLINICAL & EXPERIMENTAL METASTASIS | 297 | 1% | 0% | 3 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | INTERLEUKIN 11 | 2734448 | 21% | 43% | 95 | Search INTERLEUKIN+11 | Search INTERLEUKIN+11 |
2 | IL 11 | 1286157 | 11% | 39% | 49 | Search IL+11 | Search IL+11 |
3 | RECOMBINANT HUMAN INTERLEUKIN 11 | 665680 | 3% | 76% | 13 | Search RECOMBINANT+HUMAN+INTERLEUKIN+11 | Search RECOMBINANT+HUMAN+INTERLEUKIN+11 |
4 | INTERLEUKIN 11 RECEPTOR | 623263 | 2% | 85% | 11 | Search INTERLEUKIN+11+RECEPTOR | Search INTERLEUKIN+11+RECEPTOR |
5 | RHIL 11 | 209254 | 1% | 63% | 5 | Search RHIL+11 | Search RHIL+11 |
6 | IL 11 RECEPTOR | 150664 | 1% | 75% | 3 | Search IL+11+RECEPTOR | Search IL+11+RECEPTOR |
7 | ADIPOGENESIS INHIBITORY FACTOR | 133925 | 0% | 100% | 2 | Search ADIPOGENESIS+INHIBITORY+FACTOR | Search ADIPOGENESIS+INHIBITORY+FACTOR |
8 | GP130 TARGETING | 133925 | 0% | 100% | 2 | Search GP130+TARGETING | Search GP130+TARGETING |
9 | HYPER IL11 | 133925 | 0% | 100% | 2 | Search HYPER+IL11 | Search HYPER+IL11 |
10 | INTERLEUKIN 11 ALPHA RECEPTOR | 133925 | 0% | 100% | 2 | Search INTERLEUKIN+11+ALPHA+RECEPTOR | Search INTERLEUKIN+11+ALPHA+RECEPTOR |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | PUTOCZKI, TL , ERNST, M , (2015) IL-11 SIGNALING AS A THERAPEUTIC TARGET FOR CANCER.IMMUNOTHERAPY. VOL. 7. ISSUE 4. P. 441 -453 | 85 | 64% | 12 |
2 | NEGAHDARIPOUR, M , NEZAFAT, N , GHASEMI, Y , (2016) A PANORAMIC REVIEW AND IN SILICO ANALYSIS OF IL-11 STRUCTURE AND FUNCTION.CYTOKINE & GROWTH FACTOR REVIEWS. VOL. 32. ISSUE . P. 41 -61 | 84 | 60% | 1 |
3 | SCHWERTSCHLAG, US , TREPICCHIO, WL , DYKSTRA, KH , KEITH, JC , TURNER, KJ , DORNER, AJ , (1999) HEMATOPOIETIC, IMMUNOMODULATORY AND EPITHELIAL EFFECTS OF INTERLEUKIN-11.LEUKEMIA. VOL. 13. ISSUE 9. P. 1307 -1315 | 70 | 84% | 101 |
4 | WILLIAMS, DA , DU, XX , (1997) INTERLEUKIN-11: REVIEW OF MOLECULAR, CELL BIOLOGY, AND CLINICAL USE.BLOOD. VOL. 89. ISSUE 11. P. 3897 -3908 | 85 | 59% | 218 |
5 | PUTOCZKI, T , ERNST, M , (2010) MORE THAN A SIDEKICK: THE IL-6 FAMILY CYTOKINE IL-11 LINKS INFLAMMATION TO CANCER.JOURNAL OF LEUKOCYTE BIOLOGY. VOL. 88. ISSUE 6. P. 1109-1117 | 51 | 55% | 50 |
6 | DORNER, AJ , GOLDMAN, SJ , KEITH, JC , (1997) INTERLEUKIN-11 - BIOLOGICAL ACTIVITY AND CLINICAL STUDIES.BIODRUGS. VOL. 8. ISSUE 6. P. 418-429 | 40 | 80% | 12 |
7 | XU, DH , ZHU, ZW , WAKEFIELD, MR , XIAO, HP , BAI, Q , FANG, YJ , (2016) THE ROLE OF IL-11 IN IMMUNITY AND CANCER.CANCER LETTERS. VOL. 373. ISSUE 2. P. 156 -163 | 42 | 37% | 1 |
8 | DU, XX , WILLIAMS, DA , (1994) INTERLEUKIN-11 - A MULTIFUNCTIONAL GROWTH-FACTOR DERIVED FROM THE HEMATOPOIETIC MICROENVIRONMENT.BLOOD. VOL. 83. ISSUE 8. P. 2023-2030 | 33 | 75% | 182 |
9 | SAITOH, M , TAGUCHI, K , MOMOSE, K , SUGA, K , YAMAZAKI, N , ONO, C , SUZUKI, T , TAKEUCHI, O , YASUDA, S , MIYATA, K , (2002) RECOMBINANT HUMAN INTERLEUKIN-11 IMPROVED CARBOPLATIN-INDUCED THROMBOCYTOPENIA WITHOUT AFFECTING ANTITUMOR ACTIVITIES IN MICE BEARING LEWIS LUNG CARCINOMA CELLS.CANCER CHEMOTHERAPY AND PHARMACOLOGY. VOL. 49. ISSUE 2. P. 161-166 | 28 | 82% | 3 |
10 | NANDURKAR, HH , ROBB, L , TARLINTON, D , BARNETT, L , KONTGEN, F , BEGLEY, CG , (1997) ADULT MICE WITH TARGETED MUTATION OF THE INTERLEUKIN-11 RECEPTOR (IL11RA) DISPLAY NORMAL HEMATOPOIESIS.BLOOD. VOL. 90. ISSUE 6. P. 2148-2159 | 42 | 57% | 68 |
Classes with closest relation at Level 1 |